Reverie Labs

Reverie Labs

Computational drug discovery for cancer therapies

About Reverie Labs

Simplify's Rating
Why Reverie Labs is rated
A-
Rated B on Competitive Edge
Rated A on Growth Potential
Rated A on Rating Differentiation

Industries

AI & Machine Learning

Biotechnology

Healthcare

Company Size

11-50

Company Stage

Series A

Total Funding

$25.1M

Headquarters

Cambridge, Massachusetts

Founded

2017

Overview

Reverie Labs focuses on improving the drug discovery process, particularly for cancer therapies, by using advanced computational tools. Their approach involves machine learning and cheminformatics to quickly identify and optimize potential drug compounds, making the development process more efficient. Unlike many competitors, Reverie Labs combines expertise from various scientific fields, allowing them to tackle complex medicinal chemistry challenges effectively. Their goal is to accelerate the journey from drug discovery to clinical trials through strategic partnerships with pharmaceutical companies, such as Roche and Genentech, and by developing state-of-the-art tools for drug development.

YC Company
Simplify Jobs

Simplify's Take

What believers are saying

  • Reverie Labs raised $25 million to enhance its AI drug discovery platform.
  • Partnerships with Roche and Genentech boost Reverie's credibility and resources.
  • Growing interest in AI-driven drug discovery supports Reverie's market potential.

What critics are saying

  • Increased competition from AI-driven drug discovery startups may dilute market share.
  • Over-reliance on partnerships with major pharma companies poses strategic risks.
  • Lack of a physical lab may limit experimental validation capabilities.

What makes Reverie Labs unique

  • Reverie Labs uses machine learning to accelerate preclinical drug development.
  • The company focuses on developing innovative cancer therapies using computational tools.
  • Reverie Labs operates without traditional lab infrastructure, leveraging cloud computing.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$25.1M

Above

Industry Average

Funded Over

2 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Above Average

Industry standards

$15M
$8.2M
Discord
$15M
Canva
$25M
Reverie Labs
$30M
Kalshi

Company News

BioPharmaTrend
Mar 16th, 2024
A Busy Day for Ginkgo Bioworks

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

VentureBeat
Feb 3rd, 2021
Reverie Labs raises $25 million for its AI drug discovery platform

Reverie Labs, a company leveraging AI for drug discovery, has raised $25 million in venture capital funding.Read More

SynBioBeta
Aug 30th, 2020
A Virtual Drug Discovery Company—With No Lab Of Its Own—Partners With Roche To Fight Cancers In The Brain

By zeroing in on a notorious class of enzymes associated with cancer, Reverie Labs puts the power of cloud computing to its full potential Can two smart, motivated college grads start a pharmaceutical company in an apartment with a few laptops? Just ask Jonah Kallenbach and Ankit Gupta, co-founders of Reverie Labs. Based in Cambridge, Reverie Labs is applying […]

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Reverie Labs right now.

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →